REGENEUS LTD - Charts / Financials

33.3%

1.2¢

Currently unlisted.

A clinical-stage regenerative medicine company using stem cell technologies to develop a... A clinical-stage regenerative medicine company using stem cell technologies to develop a portfolio of novel cell-based therapies to address unmet medical needs in human health markets with a focus on neuropathic pain, including osteoarthritis and various skin conditions, with its platform technologies Progenza and Sygenus.More

REFRESH

Day chart unavailable

Last update - 15.59pm 09/04/2024 (20 minute delay)

Day
Open	1.0¢		Day High	1.4¢		Day Low	1.0¢
Daily Volume	4275678

Bids				Sellers
Number	Price	Volume		Number	Price	Volume
1	1.2¢	130918		1	1.3¢	225000

Directors & Senior Management

Mr. Barry G. Sechos	Non-Executive Chairman of the Board
Dr. Charlotte Morgan	Head - Laboratory, Research and Development
Mr. Edmund Kemp Waller	Director
Prof. Graham Vesey	Chief Scientific Officer, Executive Director
Ms. Hang Ling Leung	Company Secretary
Mr. Karolis Rosickas	Chief Executive Officer
Ms. Sandra McIntosh	Office/Human Resources Manager, Company Secretary
Mr. Terence Allen Walts	Director

Data source: ADVFN

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

REGENEUS LTD - Charts / Financials

Directors & Senior Management

Top Stories